Register Login

Oragenics Inc. (OGEN)

Director Telling Fred 🟡 adjusted position in 124.8K shares (1 derivative) of ORAGENICS INC (OGEN) at $0.94 Transaction Date: Dec 11, 2025 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Dec. 15, 2025, 9:46 p.m.

    🔍 Telling Fred (Director)

    Company: ORAGENICS INC (OGEN)

    Report Date: 2025-12-11

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 125,000
    • Total shares sold: 210

    Detailed Transactions and Holdings:

    • Sold 210 shares of Common Stock at $0.9446 per share (Direct)
      Date: 2025-12-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 34,538.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 125,000 shares of Non-Employee Director Option (Right to Buy) at $0.93 per share (Derivative)
      Date: 2025-12-11 | Code: A | Expires: 2035-12-11 | Exercise: 2025-12-11 | equity_swap_involved: 0 | shares_owned_after: 125,000.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2

    Footnotes:

    • F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
    • F2: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Search

News categories